Clinical NewsCorrectionOct 4, 2004 In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.Latest in Clinical NewsARRS: Breast RT doesn't impact presence of breast arterial calcificationsMay 2, 2025RaySearch launches v2025 RayStationMay 2, 2025IMV: PET/CT service contracts are a key aspect of system ownershipMay 2, 2025ARRS: Get involved with breast health advocacyMay 2, 2025Related StoriesBreastWhen push comes to shove: Addressing compression in mammographyBreastPreparation key to surviving MQSA inspectionsClinical NewsBiochem enters ultrasound domain in fetal screeningBreastBreast Imaging: The Requisites